Drugs / JT002
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06861101 | Feb → May 2025 | seasonal allergic rhinitis | Shanghai JunTop Biosciences Co., LTD | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | JT002 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06861101 ↗ |
| Route | Intranasal | “JT002 Nasal spray” NCT06861101 ↗ |